The objective of the study is to perform a comparative analysis of brain activity, muscle activity and upper limb kinematics during the execution of a manual motor task motivated by a VR game during AtDCS in individuals with DS. Thus, psychomotor, muscular and cognitive skills will be assessed pre, post, and follow-up intervention. The objectives of the study will be to (i) correlate variables related to movement kinematics, motor activity and brain activity, (ii) compare the effects of transcranial stimulation in individuals with DS and those with typical development (TD), (iii) determine the effects and possible adverse effects of AtDCS at an intensity of 1 mA administered during 20 minutes of training in individuals with DS and (iv) determine the effects of different AtDCS montages in individuals with DS.
The null hypothesis of the study is that the results of ten sessions of AtDCS over the F3 region of the cortex during a motor task motivated by a VR game will not differ significantly from the results obtained from ten sessions of sham tDCS with the same training in individuals with DS. The alternative hypothesis is that the results of ten sessions of AtDCS over the F3 region of the cortex during a motor task motivated by a VR game will differ significantly from the results obtained from ten sessions of sham tDCS with the same training in individuals with DS.
Ethical aspects
The present study complies with the norms governing research involving human subjects stipulated by the Brazilian National Board of Health in October 1996 and updated in Resolution 466 in 2012 as well as the precepts delineated in the Declaration of Helsinki. The study received approval from the Research Ethics Committee of the School of Medical Sciences of the Santa Casa de São Paulo (certificate number: 3.608.521) and REBEC protocol number RBR-43pk59 registered on 2019/03/27, the authors confirm that all ongoing and related trials for this drug/intervention are registered. All volunteers and their legal guardians will agree to participate in the study by signing a statement of informed consent. The participants will be allowed to abandon the study at any time with no negative consequences. Absolute confidentiality regarding the identification of individuals will be assured. The participants will be informed of the existence of a sham group prior to the start of the survey. The sham intervention procedures will always be performed in combination with active (VR training), reducing impact on the patient.
Study design
This is a protocol study for a longitudinal randomized controlled clinical trial consisting of three studies (Fig 1) and written based on the SPIRIT. The time schedule of the trial enrollment, interventions, assessments and visits of participants is displayed in Table 1.
Sample selection and characterization of healthy individuals
Individuals with typical development will be recruited from a database at the university. The inclusion criteria are no diagnosis of cognitive and/or neuromotor disorders, cooperation during the procedures and a signed statement of informed consent.
Sample selection and characterization individuals with DS
The population will be composed of individuals diagnosed with DS who will be recruited from the outpatient clinic of the University Center of Anápolis and the Association of Parents and Friends of Exceptional Children of Anápolis, which is a partner institution of the university. The inclusion criteria are a diagnosis of DS, the ability to understand procedures involved in the study, adequate cooperation, cognitive age between six and 12 years defined by the Wechsler Abbreviated Intelligence Scale (WISC) and a signed statement of informed consent. The exclusion criteria are having undergone surgical procedures in the 12 months prior to the onset of the training sessions, orthopedic deformities of the upper limbs or spine with an indication for surgery, a diagnosis of uncontrolled epilepsy, metal implants in the brain or hearing aids, other neurological disorder besides DS and the use of a pacemaker.
Evaluation of cognitive age
All individuals with DS will be assessed with regards to cognitive age using the Wechsler Abbreviated Scale of Intelligence (WASI), which is a tool designed to assess intellectual performance. This scale was developed from the Wechsler Intelligence Scale and the revised WISC-R scale for children to meet the demand for a short, reliable intelligence measure that could be used in clinical, psychoeducational and research settings while maintaining the possibility of interpreting a unified instrument. The evaluation using this scale will be performed by the psychologist in charge of the cognitive analysis.
Randomization
In Study 1, we will perform a stratified permuted block randomization to balance gender and based on individual's conditions, i.e., children with DS and children with typical development using a computer-generated random number at www.randomizacion.com. For Study 2, ten participants will be randomly divided into two groups (experimental and control); each group will consist of five volunteer The randomization method will be performed by a person who will not otherwise participate in the study.
Group allocation
The allocation to the groups will be performed with opaque and sealed envelopes. After signing the statement of informed consent, the individuals will choose an envelope with the name of the group to which they will be assigned in Studies 2 and 3. This procedure will be managed by a person who will not otherwise participate in the study.
Blinding
The researcher who will conduct the evaluations will be blinded to the group assignment and the objectives of the study and will not participate in the intervention protocols.
All electrode placement procedures will be performed in the sham group as well, but the stimulator will be switched on for only 30 seconds and will then be switched off. Thus, the subjects will have the initial sensation of electrostimulation, but will not receive any stimulation throughout the remaining time.
Data management and monitoring
Data on the participants will be collected during the eligibility assessment. Signed consent forms will be safeguarded. This study will be performed in accordance with the approved protocol. If a participant is excluded or withdraws from the study, the reason for the exclusion will be recorded.
If the participant presents any adverse effect related to the intervention process for example itching, burning sensation, headache, and pain, it will be reported to the ethics committee and procedures will be performed to ensure the participant's safety. However, due to the simplicity and safety of the protocol, we do not expect the participants to experience any adverse events.
Recruitment
Strategies will be employed to encourage participation in the study and reduce the dropout rate. The individuals with DS will be recruited from the outpatient clinic of the University Center of Anápolis and the Association of Parents and Friends of Exceptional Children of Anápolis. Parents/guardians will be contacted by telephone (or other means of communication). Pamphlets will be created with a brief description of the objectives, type of therapeutic intervention, expected results and eligible population. The researchers of the project will be responsible for this disclosure as well as leaving contact information for the parents of eligible children. The individuals selected for this study will be recruited according to the schedule registered with the ethics committee and REBEC in Dezember 2020.
Study 1
A cross-sectional study will be performed to determine the pattern of normality between individuals with DS and those with typical development. The sample selected for this study will be in accordance with the eligibility and quantity criteria for a convenience sample. The participants will be divided into two groups and each group will consist of 12 children.
Study 2
A pilot study will be conducted to determine the sample size for the longitudinal randomized controlled clinical trial. For the proper sample size calculation, the pilot study will be carried out using the same methods as those to be employed in the main study. The pilot study will involve ten children selected based on the eligibility criteria for the individuals with DS. The sample size for the clinical trial will be calculated based on the means obtained in the experimental and control groups of this pilot study, considering brain activity as the primary outcome, a unidirectional alpha of 0.05 and a power of 80%. The sample size will be then increased by 20% to compensate for possible dropouts.
Study 3
A longitudinal randomized controlled trial will be conducted. The sample will be selected based on the results of the pilot study and the individuals will be randomly distributed into two groups using a randomization website (randomization.com).
Experimental Group: AtDCS (anode placed over F3 of the International 10-20 Electroencephalogram System and the cathode placed over the right deltoid muscle) combined with VR training;
Control Group: Sham tDCS (the same electrode montages as in the experimental group) combined with VR training. At the end of the study, individuals in the sham group will receive the same stimulation protocol as the experimental group as a form of treatment to enable the same gain in functioning that we hope to find in the experimental group.
Evaluation process
The evaluation process 1 (cross-sectional study), 2 (pilot study) and 3 (clinical trial [pre-intervention, post-intervention and one-month follow-up]) will be performed according to Resolution No. 466/12 of the Brazilian National Board of Health. Each evaluation session will last a maximum of one hour and 30 minutes.
The evaluations will be performed at the Motion Analysis Laboratory of the University Center of Anapolis. Brain activity will be measured through the acquisition of electroencephalographic (EEG) signals. Muscle activity will be determined through the acquisition of electromyographic (EMG) signals. Three-dimensional motion analysis will be used for the acquisition of the kinematic data.
Initially, the identification form will be completed and the anthropometric data will be collected. The volunteers will be assessed using a non-immersive virtual reality motor task on a Dell S2240T LED 21.5" touch screen monitor. The game will consist of figures displayed in random order. The child will be instructed to touch only the figures indicated in the corner of the screen, performing a reaching motor task combined with a cognitive task of memorization and attention. After each tap (trial), the individual will return the hand to the initial support position and wait for a correct new figure to be displayed.
During the task, the EEG signals, EMG signals and upper limb kinematic data will be collected for the determination of neural signals associated with movement.
Electroencephalographic analysis: Brain activity will be investigated by electroencephalography using the eego™ sports equipment concomitantly to electromyography and the kinematic analysis. The EEG equipment is a battery-powered system with 64-channel EEG recordings and sampling up to 16 kHz.
EEG is a method for assessing the relationship between the brain and behavior and provides a direct real-time measure of neural activity, identifying critical neural mechanisms for motor performance and facilitating the recognition and modification of mental states associated with particular cortical arousal patterns and concomitant behavioral outcomes. [32-35]
The task will be performed in a small room without the possibility of external noise. Only the evaluator and child will be present. The child will be placed in the upright position on a chair adjusted so that the feet rest comfortably on the floor. The child will be seated at a square table on which the hands will rest in the starting position. A memory game will be projected on a touch monitor with possibilities of advancement in difficulty level and the subjective measurement of hits and misses. The volunteer will be oriented to perform a manual motor task, touching the screen to match figures during the memory game. After each touch (trial), the hand will return to the initial position. The task will be performed concomitantly with the EEG reading to identify neural signals associated with the movement.
The data will be preprocessed using the asa™ software, which is a highly flexible EEG/ERP and magnetoencephalography (MEG) analysis package with a variety of source reconstruction and signal analysis features.[36]
EMG Analysis: Activity of the brachial biceps and triceps muscles during the manual motor task will be determined using EMG. Electrical activity resulting from activation of elbow flexors and extensors will be collected using an eight-channel electromyograph (FREEEMG, BTS Engineering) with a bioelectric signal amplifier, wireless data transmission and bipolar electrodes with a 2000-fold total gain and frequency ranging from 20 to 450 Hz. The impedance and common rejection mode ratio of the equipment is > 1015 Ω/0.2 pF and 60/10 Hz 92 dB, respectively. The motor point of the muscles will be identified for electrode placement and the skin will be cleaned with 70% alcohol to reduce bioimpedance, following the guidelines of the Surface Electromyography for Noninvasive Muscle Assessment.37 All EMG data will be scanned at 1000 frames per second using the BTS MYOLAB software program.
Three-dimensional motion analysis: Upper limb motion kinematics will be evaluated using the SMART-D 140 system (BTS, Milan, Italy) (Fig 4), with eight infrared-sensitive cameras, a sampling frequency of 100 Hz and video system synchronized with the SMART-D system. Passive markers will be positioned at anatomical landmarks directly on the skin with specific tape following the SMARTup protocol: the experimental setup (Fig 2).[37-40] A total of 18 markers measuring 15 mm in diameter will be used to identify the position of the head, trunk and upper limbs (arm, forearm and hand).
The data from all equipment (SMART-D 140, BTS, Milan, Italy; [37-41] FREEEMG, BTS Engineering;[36] and eego™ mylab) will be collected simultaneously during the reaching task with a cognitive component. The participant will be positioned on a chair with his/her arms on the evaluation table in front of a touch monitor, which will display figures in random order. The child will be instructed to touch only the figures indicated in the corner of the screen, performing a reaching task combined with a cognitive task of memorization and attention. After each tap (trial), the hand should return to the initial support position and wait for a new correct figure to be displayed (Fig 3).
Intervention protocol
The therapeutic intervention will only be performed in Studies 2 and 3 of this protocol and will consist of a combination of tDCS and VR. The protocol will follow the safety procedures described in the literature for the use of tDCS in the population with neurological disorders. [42-50] Three 20-min sessions of tDCS concomitant with VR will be held for a total of ten sessions. [44-50]. Training is preceded by fitting and adapting the equipment to the participant. During the clinical trial, participants are prohibited initiate therapeutic activities that may be similar in the biomechanics used in the tests and in the intervention. However, it is allowed to start any other activity as long as you inform the researchers responsible for the study previously for biomechanical investigation of the new activity.
Transcranial direct current stimulation (tDCS): Stimulation will be administered using a tDCS device (DC-Stimulator NeuroConn, Germany) and two sponge (non-metallic) surface electrodes measuring 25 cm2 (5 × 5 cm) soaked in saline. The participants will be randomly allocated to two types of treatment: (1) active AtDCS; and (2) sham tDCS. The anode will be positioned over F3 of the international 10-20 electroencephalogram system and the cathode will be positioned over the right deltoid muscle. This montage (Fig 4) will enable the administration of AtDCS over the dorsolateral prefrontal cortex (DLPFC) while minimizing the effect of cathodal stimulation of the brain. The 1 mA current (current density: 0.029 mA/cm2) will be administered over the DLPFC for 20 minutes during upper limb training. The stimulator has a button that allows the operator to control the intensity of the current. Stimulation will be gradually increased to 1 mA at the beginning of the session and gradually decreased during the final 10 s of the session. Sham stimulation will consist of the same electrode montage and the stimulator will be turned on for 30 s, giving the child the initial sense of stimulation, but no current will be delivered for the remainder of the session. This is considered a valid control procedure in studies involving tDCS.[42-50] The participants will undergo a rehabilitation program while receiving tDCS. The rehabilitation program is based on the serial reaction-time task, which has been used extensively in upper limb studies. During the experiment, the participants will be seated on a chair in front of a touch screen monitor, head and arms supported (ankle angle: ~ 110°; knee angle: ~ 150°; hip angle: ~ 120°). The participants will be instructed to avoid drinking coffee or consuming other stimulants on the day of the trial.
Adverse effects: Potential adverse effects of tDCS will be assessed at the end of each session using a questionnaire administered to the child. The questionnaire will address the perception of symptoms that occurred during the session, such as tingling, itching, burning sensation, headache, pain at the electrode site, drowsiness and altered mood. The participants will be instructed to respond using a three-point scale. Caregivers and children will also receive open-ended questions at the beginning of each session addressing the occurrence of headache, scalp pain, itching, burning sensation, redness of the skin, drowsiness, difficulty concentrating and mood swings between sessions.
Virtual reality
Training sessions combined with tDCS will be held three times a week on non-consecutive days. Each session will last 20 minutes. Two training sessions will be held before the start of the intervention protocol to familiarize the participants with the procedures. Records will be made of the number of sessions attended, the duration of each session and the final score of the game based on the number of correct and incorrect taps on the screen. The entire training protocol will be carried out by a project employee with interests independent of the objective of the study.
The game will consist of five balls displayed on a touch screen. When the game starts, one of the balls will change color. At that moment, the child must touch the respective ball. After the child touches the screen, the ball returns to its original color and another ball will change color after a three-second interval. The game will consist of seven blocks: R1, R2, S1, S2, S3, R3 and S4. R blocks are those with random sequences and S blocks are those with repetitive sequences, with each block consisting of 20 sequences. A sequence is the order in which the balls change color. The sequences are either randomized or repetitive, depending on the block. Each sequence will be composed of five touches, such that 100 touches are performed by the end of each block.
Among the parameters obtained from the game for the analysis of the learning process in children with DS, the error will be calculated. The error is obtained by calculating the distance between the center of the ball and the region touched as well as the time interval between the moment that the ball changes color and the child's touch. The total error is given by the sum of the time interval and the distance between the points (touch and center of the ball) for each event.
To ensure the synchronization of the game, the acquisition of the EEG signals, the motion reconstruction and the EMG system, it will be necessary for a pulse to be sent with each child's touch. This pulse will be interpreted by an Arduino platform, which will subsequently send the information to both systems. [51-52]
FREQUENCY OF ANALYSES
Result data will be analyzed only once, at the end analysis of each study.